CLOVER HEALTH INVESTMENTS, CORP. /DE Cash Flow Statement
CLOV / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
CLOVER HEALTH INVESTMENTS, CORP. /DE used $67M in operating cash flow and negative free cash flow of $69M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | -$85.5M | -$43.0M | -$213.4M | -$339.6M | -$587.8M | -$136.4M | -$363.7M |
| Depreciation & Amortization | $1.7M | $1.3M | $2.5M | $1.2M | $1.2M | $555.0K | $551.0K |
| Operating Cash Flow | -$66.9M | $34.8M | -$144.7M | -$203.9M | -$282.3M | -$118.5M | -$159.9M |
| Capital Expenditures | $2.0M | $1.6M | $584.0K | $4.5M | $723.0K | $693.0K | $23.0K |
| Free Cash Flow | -$69.0M | $33.3M | -$145.2M | -$208.4M | -$283.0M | -$119.2M | -$159.9M |
| Share Buybacks | $18.3M | $1.8M | $0 | $0 | $147.0K | $0 | $0 |
| FCF Margin | -3.6% | 2.4% | -11.5% | -19.0% | -19.2% | -17.7% | -34.6% |